Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodríguez-Cano

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|July 18, 2002
Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosisP Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|September 10, 2003
Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activityP Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 16, 2003
[Streptomycin as second-line chemotherapy for tuberculosis]P Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|September 24, 2004
Activity of rifampin against Mycobacterium tuberculosis in a reference centerP Ruiz, J Gutierrez, F Rodríguez-Cano, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Microbial Drug Resistance (Larchmont, N.Y.)|July 18, 2002
Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosisP Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|September 10, 2003
Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activityP Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 16, 2003
[Streptomycin as second-line chemotherapy for tuberculosis]P Ruiz, F Rodríguez-Cano, F J Zerolo, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|September 24, 2004
Activity of rifampin against Mycobacterium tuberculosis in a reference centerP Ruiz, J Gutierrez, F Rodríguez-Cano, et al.
Pageof 1